Cargando…
Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923347/ https://www.ncbi.nlm.nih.gov/pubmed/36754549 http://dx.doi.org/10.1136/rmdopen-2022-002832 |
_version_ | 1784887718565642240 |
---|---|
author | Al Tabaa, Omar Ghossan, Roba Combier, Alice Steelandt, Alexia Thomas, Marion Avouac, Jerome Allanore, Yannick |
author_facet | Al Tabaa, Omar Ghossan, Roba Combier, Alice Steelandt, Alexia Thomas, Marion Avouac, Jerome Allanore, Yannick |
author_sort | Al Tabaa, Omar |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9923347 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-99233472023-02-14 Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease Al Tabaa, Omar Ghossan, Roba Combier, Alice Steelandt, Alexia Thomas, Marion Avouac, Jerome Allanore, Yannick RMD Open Systemic Sclerosis BMJ Publishing Group 2023-02-08 /pmc/articles/PMC9923347/ /pubmed/36754549 http://dx.doi.org/10.1136/rmdopen-2022-002832 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Systemic Sclerosis Al Tabaa, Omar Ghossan, Roba Combier, Alice Steelandt, Alexia Thomas, Marion Avouac, Jerome Allanore, Yannick Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease |
title | Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease |
title_full | Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease |
title_fullStr | Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease |
title_full_unstemmed | Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease |
title_short | Sustained complete B cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease |
title_sort | sustained complete b cell depletion is associated with rituximab efficacy in connective tissue disorders-associated interstitial lung disease |
topic | Systemic Sclerosis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923347/ https://www.ncbi.nlm.nih.gov/pubmed/36754549 http://dx.doi.org/10.1136/rmdopen-2022-002832 |
work_keys_str_mv | AT altabaaomar sustainedcompletebcelldepletionisassociatedwithrituximabefficacyinconnectivetissuedisordersassociatedinterstitiallungdisease AT ghossanroba sustainedcompletebcelldepletionisassociatedwithrituximabefficacyinconnectivetissuedisordersassociatedinterstitiallungdisease AT combieralice sustainedcompletebcelldepletionisassociatedwithrituximabefficacyinconnectivetissuedisordersassociatedinterstitiallungdisease AT steelandtalexia sustainedcompletebcelldepletionisassociatedwithrituximabefficacyinconnectivetissuedisordersassociatedinterstitiallungdisease AT thomasmarion sustainedcompletebcelldepletionisassociatedwithrituximabefficacyinconnectivetissuedisordersassociatedinterstitiallungdisease AT avouacjerome sustainedcompletebcelldepletionisassociatedwithrituximabefficacyinconnectivetissuedisordersassociatedinterstitiallungdisease AT allanoreyannick sustainedcompletebcelldepletionisassociatedwithrituximabefficacyinconnectivetissuedisordersassociatedinterstitiallungdisease |